Investor's Business Daily
October 2013
Investors Business Daily;10/ 9/2013, pA02
The article reports that Pfizer won't pursue a license for Lpath's iSonep, used for treatment of age-related macular degeneration.


Related Articles

  • A Closer Look at AREDS And ARMD Patients. Chew, Emily; Regillo, Carl; Cunningham Jr., Emmett T. // Review of Ophthalmology;Jun2002, Vol. 9 Issue 6, p103 

    Examines the incidence of age-related macular degeneration (AMD) among older individuals. Indication of antioxidant vitamins and zinc; Benefits of lutein and zeaxanthin; Reduction of AMD progression with antioxidant vitamins and zinc.

  • Age-related macular degeneration. Friberg, Thomas R. // Cortlandt Forum;07/25/97, Vol. 10 Issue 7, p173 

    Focuses on age-related macular degeneration (AMD), which afflicts people aged 55 and above in the United States. Definition; Symptoms; Wet and dry forms; Detection of choroidal neovascularization; Treatment of the wet form of AMD; Prevention; Rehabilitation of patients; Evaluation of patients.

  • Seeking the Giant Leap, Missing the Small Step. Glenn, Chris // Review of Ophthalmology;Aug2007 Part 1 of 2, Vol. 14 Issue 8, p19 

    The author reflects on the issues regarding age-related macular degeneration (AMD) in the U.S. He states that due to several reports and researches, confusion and misinformation have developed regarding the benefits of simple intervention on AMD patients. He suggests that public education on the...

  • LET THE LIGHT IN WITH LUTEIN. Murray, Michael T. // Alive: Canada's Natural Health & Wellness Magazine;Jan2008, Issue 303, p84 

    The article provides information on the use of lutein for the treatment of age-related macular degeneration (ARMD). It states that taking a lutein supplement may help block and reverse macular degeneration. Moreover, studies prove that taking lutein supplement increases both the lutein content....

  • Age-related macular degeneration: armed against ARMD. Weir, Erica // CMAJ: Canadian Medical Association Journal;2/17/2004, Vol. 170 Issue 4, p463 

    Provides information on the clinical manifestations of age-related macular degeneration as a cause of legal blindness among older people in North America. Presence of drusen within the basement membrane of retinal pigment epithelium; Application of opthalmoscopy; Means to prevent the disease.

  • The AMD / Cataract Surgery Connection. Arevalo, J. Fernando; Garcia, Reinaldo A.; Sanchez, Juan H. // Review of Ophthalmology;Nov2005, Vol. 12 Issue 11, p90 

    Discusses the effect of cataract surgery operation being done to age-related macular degeneration (AMD) patients in the U.S. Contribution of cataract and AMD to visual disability in patients age 60 years old or older; Studies that show both improvement and risks factors for cataract surgery to...

  • Age-Related Macular Degeneration: Update for Primary Care. Fong, Donald S. // American Family Physician;5/15/2000, Vol. 61 Issue 10, p3035 

    Presents information on age-related macular degeneration. Epidemiology; Pathophysiology; Psychosocial impact of age-related macular degeneration.

  • Retinal Microenvironment Imbalance in Dry Age-Related Macular Degeneration: A Mini-Review. Barnett, Brad P.; Handa, James T. // Gerontology;Jun2013, Vol. 59 Issue 4, p297 

    Background: Age-related macular degeneration (AMD) is the leading cause of blindness in the western world. To prevent what will certainly be a tremendous health and economic burden, effective therapeutics for AMD are urgently needed. To develop these agents in a timely fashion, the molecular...

  • Pinpointing the Earliest Defects in Age-Related Macular Degeneration.  // PLoS Medicine;Jan2006, Vol. 3 Issue 1, pe38 

    The article presents information on several studies on age-related macular degeneration (AMD). According to the article, AMD is the most common cause of blindness in later life and affects a number of people in the U.S. Genetic linkage studies found that a locus on the long arm of Chromosome 1...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics